Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials

Table 5

SUCRA values of placebo and the 7 statin treatments in NMAs conducted separately for 6 outcomes.

Treatments	LDL-C	HDL-C	TC	TG	ApoA1	ApoB
Placebo	0.4	18.3	0.4	2.3	33.7	13.8
Simvastatin	48.4	44.5	50.0	34.0	75.2	66.2
Fluvastatin	36.4	74.5	37.4	56.2	69.2	40.4
Atorvastatin	76.7	47.9	72.4	48.6	56.4	64.5
Rosuvastatin	93.1	29.9	69.5	63.1	82.8	72.9
Lovastatin	27.8	63.3	100.0	91.4	40.3	21.7
Pravastatin	47.6	62.1	24.5	67.8	18.8	56.6
Pitavastatin	69.5	59.4	45.8	36.6	23.5	63.9